Carbapenem-Resistant E. cloacae in Southwest China: Molecular Analysis of Resistance and Risk Factors for Infections Caused by NDM-1-Producers

Outbreak of Enterobacter cloacae with New Delhi metallo-β-lactamase (NDM)-1: challenges in epidemiological investigation and environmental decontamination

(2017) N. Mahida et al.   JOURNAL OF HOSPITAL INFECTION

Mechanisms Involved in Acquisition ofblaNDMGenes by IncA/C2and IncFIIYPlasmids

(2016) Alexander M. Wailan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

(2016) Li-Yang Hsu et al.   CLINICAL MICROBIOLOGY REVIEWS

Genomic Characteristics of NDM-Producing Enterobacteriaceae Isolates in Australia and TheirblaNDMGenetic Contexts

(2015) Alexander M. Wailan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dynamics of MDR Enterobacter cloacae outbreaks in a neonatal unit in Nepal: insights using wider sampling frames and next-generation sequencing

(2015) N. Stoesser et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dissemination of NDM-1-Producing Enterobacteriaceae Mediated by the IncX3-Type Plasmid

(2015) Qing Yang et al.   PLoS One

New Delhi Metallo-β-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, China

(2015) Cailin Liu et al.   PLoS One

Resistome Analysis of Enterobacter cloacae CY01, an Extensively Drug-Resistant Strain Producing VIM-1 Metallo-β-Lactamase from China

(2014) Ling Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diversity of carbapenemases in clinical isolates of Enterobacteriaceae in Croatia—the results of a multicentre study

(2014) V. Zujić Atalić et al.   CLINICAL MICROBIOLOGY AND INFECTION

Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China

(2014) Chuanming Zhang et al.   INFECTION GENETICS AND EVOLUTION

Phenotypic and Molecular Characteristics of Carbapenem-Resistant Enterobacteriaceae in a Health Care System in Los Angeles, California, from 2011 to 2013

(2014) S. Pollett et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing

(2012) Wei Dai et al.   INFECTION GENETICS AND EVOLUTION

First Report of Klebsiella oxytoca Strain Coproducing KPC-2 and IMP-8 Carbapenemases

(2011) Bin Li et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Metallo-β-lactamases: a last frontier for β-lactams?

(2011) Giuseppe Cornaglia et al.   LANCET INFECTIOUS DISEASES

Ertapenem-Resistant Enterobacteriaceae Risk Factors for Acquisition and Outcomes

(2010) E. P. Hyle et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem-resistant Enterobacter cloacae in China

(2009) Qiong Wu et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK

(2009) M. Doumith et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

(2009) Patrice Nordmann et al.   LANCET INFECTIOUS DISEASES